Jane Street’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-326,937
| Closed | -$176K | – | 5515 |
|
|
2024
Q4 | $176K | Buy |
326,937
+152,780
| +88% | +$82.3K | ﹤0.01% | 5152 |
|
|
2024
Q3 | $166K | Buy |
174,157
+98,581
| +130% | +$93.7K | ﹤0.01% | 5321 |
|
|
2024
Q2 | $73.7K | Buy |
+75,576
| New | +$73.7K | ﹤0.01% | 5688 |
|
|
2024
Q1 | – | Sell |
-97,580
| Closed | -$77.4K | – | 5713 |
|
|
2023
Q4 | $77.4K | Buy |
+97,580
| New | +$77.4K | ﹤0.01% | 5326 |
|
|
2022
Q3 | – | Sell |
-44,086
| Closed | -$75K | – | 5691 |
|
|
2022
Q2 | $75K | Buy |
+44,086
| New | +$75K | ﹤0.01% | 4833 |
|
|
2022
Q1 | – | Sell |
-20,249
| Closed | -$76K | – | 5575 |
|
|
2021
Q4 | $76K | Sell |
20,249
-21,681
| -52% | -$81.4K | ﹤0.01% | 4754 |
|
|
2021
Q3 | $216K | Buy |
41,930
+11,234
| +37% | +$57.9K | ﹤0.01% | 4325 |
|
|
2021
Q2 | $130K | Buy |
30,696
+12,381
| +68% | +$52.4K | ﹤0.01% | 4661 |
|
|
2021
Q1 | $97K | Sell |
18,315
-10,058
| -35% | -$53.3K | ﹤0.01% | 4574 |
|
|
2020
Q4 | $153K | Buy |
+28,373
| New | +$153K | ﹤0.01% | 3549 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3704 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3914 |
|
|
2018
Q2 | – | Sell |
-14,947
| Closed | -$168K | – | 3197 |
|
|
2018
Q1 | $168K | Buy |
+14,947
| New | +$168K | ﹤0.01% | 2855 |
|